* Alimera Sciences Inc ALIM.OQ reported a quarterly adjusted
loss of 63 cents per share for the quarter ended in March. The
mean expectation of four analysts for the quarter was for a loss
of 54 cents per share.
* Revenue fell 22.8% to $11.21 million from a year ago;
analysts expected $12.07 million.
* Alimera Sciences Inc's reported EPS for the quarter was a loss
of 63 cents.
* The mean earnings estimate of analysts had fallen by
about 575% in the last three months.
* In the last 30 days one analyst negatively revised an earnings
estimate and
* Alimera Sciences Inc shares had risen by 15.0% this
quarter and gained 162.1% so far this year.
* The company reported a quarterly loss of $3.65 million.
* Wall Street's median 12-month price target for Alimera
Sciences Inc is $15.75
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 4 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."
This summary was machine generated April 29 at 01:33 a.m. GMT.
All figures in US Dollars.